Author:
Yu Wangie,Chen Yunyun,Dubrulle Julien,Stossi Fabio,Putluri Vasanta,Sreekumar Arun,Putluri Nagireddy,Baluya Dodge,Lai Stephen Y.,Sandulache Vlad C.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Hernlund, E., Hjerpe, E., Avall-Lundqvist, E. & Shoshan, M. Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment. Mol Cancer Ther 8, 1916–1923, https://doi.org/1535-7163.MCT-09-0179 (2009).
2. Pignon, J. P., le Maitre, A., Maillard, E. & Bourhis, J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92, 4–14, https://doi.org/S0167-8140(09)00188-1 (2009).
3. Robson, H. et al. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines. Med Pediatr Oncol 39, 573–580, https://doi.org/10.1002/mpo.10076 (2002).
4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324, 1685–1690, https://doi.org/10.1056/NEJM199106133242402 (1991).
5. Ahmed, Z., Deyama, Y., Yoshimura, Y. & Suzuki, K. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+, K+−ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B. Cancer Chemother Pharmacol 63, 643–650, https://doi.org/10.1007/s00280-008-0781-z (2009).
Cited by
98 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献